The red part is to good to be true UNLESS again the profits are kept low by Oncology Inc who sets up a system that the profits are wheeled in in another entity.
Oncology could license the IP to another company and that income would be the commercialization revenue. The REAL margin, mark up on treatement cost, would end up in other pockets.